BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 23727036)

  • 1. A homozygous mucosa-associated lymphoid tissue 1 (MALT1) mutation in a family with combined immunodeficiency.
    Jabara HH; Ohsumi T; Chou J; Massaad MJ; Benson H; Megarbane A; Chouery E; Mikhael R; Gorka O; Gewies A; Portales P; Nakayama T; Hosokawa H; Revy P; Herrod H; Le Deist F; Lefranc G; Ruland J; Geha RS
    J Allergy Clin Immunol; 2013 Jul; 132(1):151-8. PubMed ID: 23727036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined immunodeficiency due to MALT1 mutations, treated by hematopoietic cell transplantation.
    Punwani D; Wang H; Chan AY; Cowan MJ; Mallott J; Sunderam U; Mollenauer M; Srinivasan R; Brenner SE; Mulder A; Claas FH; Weiss A; Puck JM
    J Clin Immunol; 2015 Feb; 35(2):135-46. PubMed ID: 25627829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel MALT1 Mutation Linked to Immunodeficiency, Immune Dysregulation, and an Abnormal T Cell Receptor Repertoire.
    Frizinsky S; Rechavi E; Barel O; Najeeb RH; Greenberger S; Lee YN; Simon AJ; Lev A; Ma CA; Sun G; Blackstone SA; Milner JD; Somech R; Stauber T
    J Clin Immunol; 2019 May; 39(4):401-413. PubMed ID: 31037583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive B cell depletion in human MALT1 deficiency.
    Sonoda M; Ishimura M; Eguchi K; Yada Y; Lenhartová N; Shiraishi A; Tanaka T; Sakai Y; Ohga S
    Clin Exp Immunol; 2021 Dec; 206(3):237-247. PubMed ID: 34559885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency in Mucosa-associated Lymphoid Tissue Lymphoma Translocation 1: A Novel Cause of IPEX-Like Syndrome.
    Charbit-Henrion F; Jeverica AK; Bègue B; Markelj G; Parlato M; Avčin SL; Callebaut I; Bras M; Parisot M; Jazbec J; Homan M; Ihan A; Rieux-Laucat F; Stolzenberg MC; Ruemmele FM; Avčin T; Cerf-Bensussan N;
    J Pediatr Gastroenterol Nutr; 2017 Mar; 64(3):378-384. PubMed ID: 27253662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of protein kinase C theta, Bcl10, or Malt1 selectively impairs proliferation and NF-kappa B activation in the CD4+ T cell subset.
    Kingeter LM; Schaefer BC
    J Immunol; 2008 Nov; 181(9):6244-54. PubMed ID: 18941215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protease activity of the paracaspase MALT1 is controlled by monoubiquitination.
    Pelzer C; Cabalzar K; Wolf A; Gonzalez M; Lenz G; Thome M
    Nat Immunol; 2013 Apr; 14(4):337-45. PubMed ID: 23416615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refining the dermatological spectrum in primary immunodeficiency: mucosa-associated lymphoid tissue lymphoma translocation protein 1 deficiency mimicking Netherton/Omenn syndromes.
    Wiegmann H; Reunert J; Metze D; Marquardt T; Engel T; Kunde V; Ehl S; Foell D; van den Heuvel I; Oji V; Wittkowski H
    Br J Dermatol; 2020 Jan; 182(1):202-207. PubMed ID: 31049936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The paracaspase MALT1 cleaves HOIL1 reducing linear ubiquitination by LUBAC to dampen lymphocyte NF-κB signalling.
    Klein T; Fung SY; Renner F; Blank MA; Dufour A; Kang S; Bolger-Munro M; Scurll JM; Priatel JJ; Schweigler P; Melkko S; Gold MR; Viner RI; Régnier CH; Turvey SE; Overall CM
    Nat Commun; 2015 Nov; 6():8777. PubMed ID: 26525107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MALT1--a universal soldier: multiple strategies to ensure NF-κB activation and target gene expression.
    Afonina IS; Elton L; Carpentier I; Beyaert R
    FEBS J; 2015 Sep; 282(17):3286-97. PubMed ID: 25996250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The t(14;18)(q32;q21)/IGH-MALT1 translocation in MALT lymphomas contains templated nucleotide insertions and a major breakpoint region similar to follicular and mantle cell lymphoma.
    Murga Penas EM; Callet-Bauchu E; Ye H; Gazzo S; Berger F; Schilling G; Albert-Konetzny N; Vettorazzi E; Salles G; Wlodarska I; Du MQ; Bokemeyer C; Dierlamm J
    Blood; 2010 Mar; 115(11):2214-9. PubMed ID: 19965626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells.
    Ho L; Davis RE; Conne B; Chappuis R; Berczy M; Mhawech P; Staudt LM; Schwaller J
    Blood; 2005 Apr; 105(7):2891-9. PubMed ID: 15598810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of CARMA1-BCL10-MALT1-A20-NF-κB expression in T cell-acute lymphocytic leukemia.
    Ma Y; Liao Z; Xu Y; Zhong Z; Wang X; Zhang F; Chen S; Yang L; Luo G; Huang X; Huang S; Wu X; Li Y
    Eur J Med Res; 2014 Nov; 19(1):62. PubMed ID: 25384343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway.
    Lucas PC; Yonezumi M; Inohara N; McAllister-Lucas LM; Abazeed ME; Chen FF; Yamaoka S; Seto M; Nunez G
    J Biol Chem; 2001 Jun; 276(22):19012-9. PubMed ID: 11262391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of MALT1 oncogene in hematopoietic stem/progenitor cells recapitulates the pathogenesis of human lymphoma in mice.
    Vicente-Dueñas C; Fontán L; Gonzalez-Herrero I; Romero-Camarero I; Segura V; Aznar MA; Alonso-Escudero E; Campos-Sanchez E; Ruiz-Roca L; Barajas-Diego M; Sagardoy A; Martinez-Ferrandis JI; Abollo-Jimenez F; Bertolo C; Peñuelas I; Garcia-Criado FJ; García-Cenador MB; Tousseyn T; Agirre X; Prosper F; Garcia-Bragado F; McPhail ED; Lossos IS; Du MQ; Flores T; Hernandez-Rivas JM; Gonzalez M; Salar A; Bellosillo B; Conde E; Siebert R; Sagaert X; Cobaleda C; Sanchez-Garcia I; Martinez-Climent JA
    Proc Natl Acad Sci U S A; 2012 Jun; 109(26):10534-9. PubMed ID: 22689981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malt1 ubiquitination triggers NF-kappaB signaling upon T-cell activation.
    Oeckinghaus A; Wegener E; Welteke V; Ferch U; Arslan SC; Ruland J; Scheidereit C; Krappmann D
    EMBO J; 2007 Nov; 26(22):4634-45. PubMed ID: 17948050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibitor of apoptosis protein fusion c-IAP2.MALT1 stimulates NF-kappaB activation independently of TRAF1 AND TRAF2.
    Varfolomeev E; Wayson SM; Dixit VM; Fairbrother WJ; Vucic D
    J Biol Chem; 2006 Sep; 281(39):29022-9. PubMed ID: 16891304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinatorial BTK and MALT1 inhibition augments killing of CD79 mutant diffuse large B cell lymphoma.
    Nagel D; Bognar M; Eitelhuber AC; Kutzner K; Vincendeau M; Krappmann D
    Oncotarget; 2015 Dec; 6(39):42232-42. PubMed ID: 26540570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autocleavage of the paracaspase MALT1 at Arg-781 attenuates NF-κB signaling and regulates the growth of activated B-cell like diffuse large B-cell lymphoma cells.
    Wu CH; Yang YH; Chen MR; Tsai CH; Cheng AL; Doong SL
    PLoS One; 2018; 13(6):e0199779. PubMed ID: 29953499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl10/Malt1 signaling is essential for TCR-induced NF-kappaB activation in thymocytes but dispensable for positive or negative selection.
    Jost PJ; Weiss S; Ferch U; Gross O; Mak TW; Peschel C; Ruland J
    J Immunol; 2007 Jan; 178(2):953-60. PubMed ID: 17202357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.